Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2008, Article ID 513854, 7 pages
http://dx.doi.org/10.1155/2008/513854
Review Article

Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children

Children's Healthcare of Atlanta, Emory University School of Medicine, 5445 Meridian Mark Road, Suite 420, Atlanta, GA 30342, USA

Received 8 January 2008; Accepted 14 May 2008

Academic Editor: Walid A. Farhat

Copyright © 2008 Wolfgang H. Cerwinka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. H. Jacobson, S. Hansson, and B. Jakobsson, “Vesico-ureteric reflux: occurrence and long-term risks,” Acta Paediatrica, vol. 88, pp. 22–30, 1999. View at Google Scholar
  2. J. S. Elder, C. A. Peters, B. S. Arant, Jr. et al., “Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children,” The Journal of Urology, vol. 157, no. 5, pp. 1846–1851, 1997. View at Publisher · View at Google Scholar
  3. E. Matouschek, “Die Behandlung des vesikorenalen Refluxes durch transurethrale Einspritzung von Teflonpaste,” Der Urologe Ausgabe A, vol. 20, no. 5, pp. 263–264, 1981. View at Google Scholar
  4. B. O'Donnell and P. Puri, “Treatment of vesicoureteric reflux by endoscopic injection of Teflon,” British Medical Journal, vol. 289, no. 6436, pp. 7–9, 1984. View at Google Scholar
  5. A. J. Kirsch, M. Perez-Brayfield, E. A. Smith, and H. C. Scherz, “The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter,” The Journal of Urology, vol. 171, no. 6, part 1, pp. 2413–2416, 2004. View at Publisher · View at Google Scholar
  6. R. N. Yu and D. R. Roth, “Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon,” Pediatrics, vol. 118, no. 2, pp. 698–703, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. U. Jodal, J. M. Smellie, H. Lax, and P. F. Hoyer, “Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children,” Pediatric Nephrology, vol. 21, no. 6, pp. 785–792, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. A. Stenberg and G. Läckgren, “Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study,” Journal of Pediatric Urology, vol. 3, no. 2, pp. 80–85, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. J. M. Elmore, A. J. Kirsch, E. A. Heiss, A. Gilchrist, and H. C. Scherz, “Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation,” The Journal of Urology, vol. 179, no. 6, pp. 2364–2368, 2008. View at Publisher · View at Google Scholar · View at PubMed
  10. K. Ogan, H. G. Pohl, D. Carlson, A. B. Belman, and H. G. Rushton, “Parental preferences in the management of vesicoureteral reflux,” The Journal of Urology, vol. 166, no. 1, pp. 240–243, 2001. View at Publisher · View at Google Scholar
  11. N. Capozza, A. Lais, E. Matarazzo, S. Nappo, M. Patricolo, and P. Caione, “Treatment of vesico-ureteric reflux: a new algorithm based on parental preference,” BJU International, vol. 92, no. 3, pp. 285–288, 2003. View at Publisher · View at Google Scholar
  12. J. M. Elmore, A. J. Kirsch, M. R. Perez-Brayfield, H. C. Scherz, and M. A. Koyle, “Salvage extravesical ureteral reimplantation after failed endoscopic surgery for vesicoureteral reflux,” The Journal of Urology, vol. 176, no. 3, pp. 1158–1160, 2006. View at Publisher · View at Google Scholar · View at PubMed
  13. M. Perez-Brayfield, A. J. Kirsch, T. W. Hensle, M. A. Koyle, P. Furness, and H. C. Scherz, “Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux,” The Journal of Urology, vol. 172, no. 4, supplement 1, pp. 1614–1616, 2004. View at Publisher · View at Google Scholar
  14. D. Kitchens, E. Minevich, W. DeFoor et al., “Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy,” The Journal of Urology, vol. 176, no. 4, supplement 1, pp. 1861–1863, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. A. A. Malizia, Jr., H. M. Reiman, R. P. Myers et al., “Migration and granulomatous reaction after periurethral injection of polytef (Teflon),” Journal of the American Medical Association, vol. 251, no. 24, pp. 3277–3281, 1984. View at Publisher · View at Google Scholar
  16. P. A. Dewan, “Is injected polytetrafluoroethylene (Polytef) carcinogenic?,” British Journal of Urology, vol. 69, no. 1, pp. 29–33, 1992. View at Google Scholar
  17. I. A. Aaronson, R. A. Rames, W. B. Greene, L. G. Walsh, U. A. Hasal, and P. D. Garen, “Endoscopic treatment of reflux: migration of Teflon to the lungs and brain,” European Urology, vol. 23, no. 3, pp. 394–399, 1993. View at Google Scholar
  18. D. R. Henly, D. M. Barrett, T. L. Weiland, M. K. O'Connor, A. A. Malizia, and A. J. Wein, “Particulate silicone for use in periurethral injections: local tissue effects and search for migration,” The Journal of Urology, vol. 153, no. 6, pp. 2039–2043, 1995. View at Publisher · View at Google Scholar
  19. E. C. Janowsky, L. L. Kupper, and B. S. Hulka, “Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases,” The New England Journal of Medicine, vol. 342, no. 11, pp. 781–790, 2000. View at Publisher · View at Google Scholar
  20. L. Cooperman and D. Michaeli, “The immunogenicity of injectable collagen—II: a retrospective review of seventy-two tested and treated patients,” Journal of the American Academy of Dermatology, vol. 10, no. 4, pp. 647–651, 1984. View at Google Scholar
  21. Å. Stenberg, E. Larsson, A. Lindholm, B. Ronneus, A. Stenberg, and G. Läckgren, “Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis,” Scandinavian Journal of Urology and Nephrology, vol. 33, no. 6, pp. 355–361, 1999. View at Publisher · View at Google Scholar
  22. A. Stenberg, E. Larsson, and G. Läckgren, “Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings,” The Journal of Urology, vol. 169, no. 3, pp. 1109–1113, 2003. View at Publisher · View at Google Scholar · View at PubMed
  23. L. P. McMann, H. C. Scherz, and A. J. Kirsch, “Long-term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic volumetric analysis,” The Journal of Urology, vol. 177, no. 1, pp. 316–320, 2007. View at Publisher · View at Google Scholar · View at PubMed
  24. J. A. Molitierno, H. C. Scherz, and A. J. Kirsch, “Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer,” Journal of Pediatric Urology. In press. View at Publisher · View at Google Scholar · View at PubMed
  25. N. Capozza, A. Lais, E. Matarazzo, S. Nappo, M. Patricolo, and P. Caione, “Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux,” The Journal of Urology, vol. 168, no. 4, supplement 1, pp. 1695–1698, 2002. View at Publisher · View at Google Scholar
  26. J. M. Elmore, H. C. Scherz, and A. J. Kirsch, “Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure,” The Journal of Urology, vol. 175, no. 2, pp. 712–715, 2006. View at Publisher · View at Google Scholar · View at PubMed
  27. J. S. Elder, M. Diaz, A. A. Caldamone et al., “Endoscopic therapy for vesicoureteral reflux: a meta-analysis—I: reflux resolution and urinary tract infection,” The Journal of Urology, vol. 175, no. 2, pp. 716–722, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. G. Läckgren, N. Wåhlin, E. Sköldenberg, and A. Stenberg, “Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux,” The Journal of Urology, vol. 166, no. 5, pp. 1887–1892, 2001. View at Publisher · View at Google Scholar
  29. J. B. Campbell, T. S. Lendvay, M. C. Risk et al., “Endoscopic treatment of symptomatic refluxing renal transplant ureteroneocystostomies in children,” in Proceedings of the Annual Meeting of the American Urological Association, Anaheim, Calif, USA, May 2007.
  30. J. A. Molitierno, Jr., H. C. Scherz, and A. J. Kirsch, “Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters,” Journal of Pediatric Urology. In press. View at Publisher · View at Google Scholar · View at PubMed
  31. W. H. Cerwinka, H. C. Scherz, and A. J. Kirsch, “Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children,” The Journal of Urology, vol. 178, no. 4, pp. 1469–1473, 2007. View at Publisher · View at Google Scholar · View at PubMed
  32. B. Chertin, N. Mohanan, A. Farkas, and P. Puri, “Endoscopic treatment of vesicoureteral reflux associated with ureterocele,” The Journal of Urology, vol. 178, no. 4, supplement 1, pp. 1594–1597, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. N. Capozza, A. Lais, S. Nappo, and P. Caione, “The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience,” The Journal of Urology, vol. 172, no. 4, supplement 1, pp. 1626–1629, 2004. View at Publisher · View at Google Scholar
  34. A. J. Kirsch, J. M. Elmore, J. Molitierno, and H. C. Scherz, “The double HIT methodology for the endoscopic correction of vesicoureteral reflux,” in Proceedings of the Annual Meeting of the American Urological Association, Atlanta, Ga, USA, May 2006.
  35. J.-W. van Capelle, T. de Haan, W. El Sayed, and A. Azmy, “The long-term outcome of the endoscopic subureteric implantation of polydimethylsiloxane for treating vesico-ureteric reflux in children: a retrospective analysis of the first 195 consecutive patients in two European centres,” BJU International, vol. 94, no. 9, pp. 1348–1351, 2004. View at Publisher · View at Google Scholar · View at PubMed
  36. A.-M. Kajbafzadeh, Z. Habibi, and P. Tajik, “Endoscopic subureteral urocol injection for the treatment of vesicoureteral reflux,” The Journal of Urology, vol. 175, no. 4, pp. 1480–1483, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. P. Puri, M. Pirker, N. Mohanan, M. Dawrant, L. Dass, and E. Colhoun, “Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux,” The Journal of Urology, vol. 176, no. 4, supplement 1, pp. 1856–1860, 2006. View at Publisher · View at Google Scholar · View at PubMed
  38. A. J. Lorenzo, J. L. Pippi Salle, U. Barroso et al., “What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years,” The Journal of Urology, vol. 176, no. 4, supplement 1, pp. 1851–1855, 2006. View at Publisher · View at Google Scholar · View at PubMed
  39. K. J. Pinto, J. Pugach, and J. Saalfield, “Lack of usefulness of positioned instillation of contrast cystogram after injection of dextranomer/hyaluronic acid,” The Journal of Urology, vol. 176, no. 6, pp. 2654–2656, 2006. View at Publisher · View at Google Scholar · View at PubMed
  40. M. T. Lavelle, M. J. Conlin, and S. J. Skoog, “Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success,” Urology, vol. 65, no. 3, pp. 564–567, 2005. View at Publisher · View at Google Scholar · View at PubMed
  41. S. Yucel, A. Gupta, and W. Snodgrass, “Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux,” The Journal of Urology, vol. 177, no. 4, pp. 1505–1509, 2007. View at Publisher · View at Google Scholar · View at PubMed
  42. J. C. Routh, Y. Reinberg, R. A. Ashley et al., “Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection,” The Journal of Urology, vol. 178, no. 4, supplement 1, pp. 1702–1706, 2007. View at Publisher · View at Google Scholar · View at PubMed
  43. G. Kobelt, D. A. Canning, T. W. Hensle, and G. Läckgren, “The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux,” The Journal of Urology, vol. 169, no. 4, pp. 1480–1484, 2003. View at Publisher · View at Google Scholar · View at PubMed
  44. R. M. Benoit, P. B. Peele, and S. G. Docimo, “The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management,” The Journal of Urology, vol. 176, no. 4, pp. 1588–1592, 2006. View at Publisher · View at Google Scholar · View at PubMed
  45. D. R. Vandersteen, J. C. Routh, A. J. Kirsch et al., “Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer,” The Journal of Urology, vol. 176, no. 4, pp. 1593–1595, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. C. S. Cooper, B. I. Chung, A. J. Kirsch, D. A. Canning, and H. M. Snyder, III, “The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux,” The Journal of Urology, vol. 163, no. 1, pp. 269–273, 2000. View at Publisher · View at Google Scholar